Lyra Therapeutics
Michael Altman was a trader and analyst at First New York Securities from October 2005 to October 2007. Michael is currently a board member at Lyra Therapeutics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lyra Therapeutics
Creating precisely tuned medicines so patients can breathe freely, Lyra Therapeutics is pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that impact the lives of millions of people.